[go: up one dir, main page]

NO951811L - Kinolin- og benzimidazolderivater, deres fremstilling og anvendelse - Google Patents

Kinolin- og benzimidazolderivater, deres fremstilling og anvendelse

Info

Publication number
NO951811L
NO951811L NO951811A NO951811A NO951811L NO 951811 L NO951811 L NO 951811L NO 951811 A NO951811 A NO 951811A NO 951811 A NO951811 A NO 951811A NO 951811 L NO951811 L NO 951811L
Authority
NO
Norway
Prior art keywords
quinoline
preparation
benzimidazole derivatives
group
general formula
Prior art date
Application number
NO951811A
Other languages
English (en)
Other versions
NO951811D0 (no
Inventor
George Pascal
Mireille Sevrin
Michel Peynot
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO951811D0 publication Critical patent/NO951811D0/no
Publication of NO951811L publication Critical patent/NO951811L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/16—Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

orbindelser med generell formel (I). hvor n representerer 1 eller 2, X representerer H eller ett eller to atomer eller grupper valgt blant fluor, klor og gruppene (-0alkyl, C^- C-^ alkoksy og hydroksy, og R representerer enten H eller en gruppe med generell formel -CHj-CC-R(hvor Rrepresenterer H eller en C-Calkyl-gruppe), eller en gruppe med generell formel -CH-CO-NRR(hvor Rog Rhver representerer H eller en CCalkyl-gruppe.orbindelsene har terapeutisk anvendelse.
NO951811A 1994-05-10 1995-05-09 Kinolin- og benzimidazolderivater, deres fremstilling og anvendelse NO951811L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9405715A FR2719843B1 (fr) 1994-05-10 1994-05-10 Dérivés de 5,6-dihydro-4h-imidazo [2',1':2,3] imidazo-[4,5,1-ij] quinoléine et de 4,5-dihydroimidazo [1,2-a] pyrrolo-[1,2,3-cd] benzimidazole, leur préparation et leur application en thérapeutique.

Publications (2)

Publication Number Publication Date
NO951811D0 NO951811D0 (no) 1995-05-09
NO951811L true NO951811L (no) 1995-11-13

Family

ID=9463058

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951811A NO951811L (no) 1994-05-10 1995-05-09 Kinolin- og benzimidazolderivater, deres fremstilling og anvendelse

Country Status (18)

Country Link
US (1) US5512590A (no)
EP (1) EP0682025A1 (no)
JP (1) JPH0853450A (no)
KR (1) KR950032193A (no)
CN (1) CN1115761A (no)
AU (1) AU1793595A (no)
CA (1) CA2148951A1 (no)
CZ (1) CZ119495A3 (no)
FI (1) FI952249A7 (no)
FR (1) FR2719843B1 (no)
HU (1) HUT72666A (no)
IL (1) IL113672A (no)
NO (1) NO951811L (no)
NZ (1) NZ272089A (no)
PL (1) PL308517A1 (no)
RU (1) RU95107157A (no)
SK (1) SK59695A3 (no)
ZA (1) ZA953750B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0120345D0 (en) * 2001-08-21 2001-10-17 Merck Sharp & Dohme Therapeutic agents
CA2509561A1 (en) * 2002-12-18 2004-07-15 Mallinckrodt Inc. Synthesis of heteroaryl acetamides
ATE451371T1 (de) * 2004-06-22 2009-12-15 Mallinckrodt Inc Synthese von heteroarylacetamiden aus reaktionsmischungen mit reduziertem wassergehalt
JP2008538748A (ja) * 2005-04-07 2008-11-06 ハイシアム， インコーポレイテッド 不安、物質乱用及び依存の予防のための改良型方法及び組成物
US7812013B2 (en) 2005-06-14 2010-10-12 Schering Corporation Macrocyclic heterocyclic aspartyl protease inhibitors
US12522583B2 (en) 2018-11-07 2026-01-13 Dana-Farber Cancer Institute, Inc. Benzimidazole derivatives and aza-benzimidazole derivatives as Janus kinase 2 inhibitors and uses thereof
US12415816B2 (en) 2018-11-07 2025-09-16 Dana-Farber Cancer Institute, Inc. Benzothiazole derivatives and 7-aza-benzothiazole derivatives as janus kinase 2 inhibitors and uses thereof
WO2020097400A1 (en) 2018-11-07 2020-05-14 Dana-Farber Cancer Institute, Inc. Imidazopyridine derivatives and aza-imidazopyridine derivatives as janus kinase 2 inhibitors and uses thereof
US20240360132A9 (en) * 2019-10-03 2024-10-31 Dana-Farber Cancer Institute, Inc. Tricyclic kinase inhibitors and uses thereof
EP4146639A1 (en) 2020-05-06 2023-03-15 Ajax Therapeutics, Inc. 6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors
TW202241889A (zh) 2020-12-23 2022-11-01 美商雅捷可斯治療公司 作為ｊａｋ２抑制劑之６－雜芳基氧基苯并咪唑及氮雜苯并咪唑
WO2023086319A1 (en) 2021-11-09 2023-05-19 Ajax Therapeutics, Inc. 6-he tero aryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors
TW202325289A (zh) 2021-11-09 2023-07-01 美商雅捷可斯治療公司 Ｊａｋ２抑制劑之形式及組合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3732243A (en) * 1970-06-23 1973-05-08 Sankyo Co 2-(p-bromophenyl)-9-dimethyl-amino-propyl-9h-imidazo(1,2-a)benzimidazole
FR2568879B1 (fr) * 1984-08-07 1986-12-12 Synthelabo Imidazo(1,2-a)quinolines, leur preparation et leur application en therapeutique
FR2593817B1 (fr) * 1986-01-31 1988-04-15 Synthelabo Derives de tetrahydro-5,6,7,8 imidazo(1,2-a)pyridine, leur preparation et leur application en therapeutique
KR0167346B1 (ko) * 1989-06-09 1999-01-15 로버트 에이. 아미테이지 중추신경계 활성을 갖는 헤테로사이클릭 아민
EP0607076A1 (fr) * 1993-01-15 1994-07-20 Synthelabo Dérivés de 9h-imidazo 1,2-a benzimidazole-3-acétamide à activité GABA

Also Published As

Publication number Publication date
FI952249A0 (fi) 1995-05-09
NO951811D0 (no) 1995-05-09
KR950032193A (ko) 1995-12-20
FR2719843A1 (fr) 1995-11-17
ZA953750B (en) 1996-04-02
FI952249L (fi) 1995-11-11
US5512590A (en) 1996-04-30
CA2148951A1 (en) 1995-11-11
JPH0853450A (ja) 1996-02-27
CZ119495A3 (en) 1995-12-13
NZ272089A (en) 1996-07-26
IL113672A0 (en) 1995-08-31
FR2719843B1 (fr) 1996-06-07
AU1793595A (en) 1995-11-16
IL113672A (en) 1997-11-20
SK59695A3 (en) 1995-12-06
EP0682025A1 (fr) 1995-11-15
FI952249A7 (fi) 1995-11-11
PL308517A1 (en) 1995-11-13
CN1115761A (zh) 1996-01-31
RU95107157A (ru) 1997-03-20
HUT72666A (en) 1996-05-28

Similar Documents

Publication Publication Date Title
NO951811L (no) Kinolin- og benzimidazolderivater, deres fremstilling og anvendelse
DK0699200T3 (da) Dihalogentriazolopyrimidinderivater som fungicider
NO941101L (no) Quinazolin-derivater
ATE204875T1 (de) Fungizide tetrahydrofurane
MEP24608A (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
DK0779886T3 (da) Dihydrobenzofuran og beslægtede forbindelser, der er anvendelige som antiinflammatoriske midler
ATE223235T1 (de) Chitosan induzierte verstärkung
NO913725L (no) Benzen-, pyridin- og pyrimidin-derivater og fremgangsmaatefor deres fremstilling.
TW360652B (en) Acryloyl substituted disstamycin derivatives, process for preparing them, and pharmaceutical composition comprising them
NO20001781L (no) 3-amino-3-arylpropan-1-og lignende-derivater, deres fremstilling og anvendelse
NO982566L (no) Forbindelser
DE69001111D1 (de) Antikrebs-zusammensetzung.
NO902336L (no) Antispasmotiske midler.
ES2055235T3 (es) Composicion anti-inflamatoria y/o antialergica que comprende derivados de glutation.
FI884088A0 (fi) Foerfarande foer framstaellning av 17-substituerade androsta-1,4-dien-3-onderivat.
DE69617909D1 (de) 2-substituierte vitamin-d3-derivate
DE60203528D1 (de) Oberflächenaktive verbindungen
MX9206930A (es) Nuevos compuestos
DE69112070D1 (de) Anthelmintische und coccidizide 3-carbamoyl-4-hydroxycumarine, ihre verwendung und zusammensetzungen.
NO167029C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinkarboksylsyrederivater
DE69828390D1 (de) Diaminotrifluoromethylpyrimidinderivate enthaltende antikrebs-zusammensetzung
ATE86117T1 (de) Zusammensetzung gegen leberkrankheiten.
DK455285D0 (da) 2-pyridin-thiolderivater
NO164474C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heksahydropyrrolo(2,1-a)isokinolin-derivater.
ATE139764T1 (de) Substituierte benzoate-derivate